Presentation ACC 2026

Evolocumab in Patients without Known Atherosclerosis and with Diabetes: Secondary Analysis from VESALIUS-CV

Presenter: Nicholas Marston

March 28, 2026

REGISTER for free or LOG IN to view this content

Evolocumab in Patients without Known Atherosclerosis and with Diabetes: Secondary Analysis from VESALIUS-CV

Prevention

Diabetes

Lipids

Presentation

ACC 2026

Up Next

Presentation ACC 2026

Essence-TIMI 73b CCTA Trial: Effect of APOC3 Inhibition with Olezarsen on Coronary Atherosclerosis

Presenter: Nicholas Marston

March 30, 2026

More slides +

Presentation ACC 2026

The STEMI Door to Unload Trial (STEMI-DTU)

Presenter: Gregg Stone

March 28, 2026

Presentation ACC 2026

Controlled trial of High-risk coronary Intervention with Percutaneous left ventricular unloading (CHIP-BCIS3)

Presenter: Divaka Perera

March 29, 2026

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.